ArticleCureus2025
When Blood Leaves a Trace: Diagnosing Superficial Siderosis in a Geriatric Patient.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superficial siderosis (SS) is a rare neurodegenerative condition caused by chronic or recurrent bleeding into the subarachnoid space, leading to the deposition of hemosiderin in the subpial layers of the brain, brainstem, spinal cord, or cranial nerves. SS is categorized into two main forms based on its anatomical distribution: cortical superficial siderosis (cSS) and infratentorial superficial siderosis (iSS). Among these, iSS is further subdivided into Type 1 (classical iSS) and Type 2 (secondary iSS). Classical iSS refers to cases in which there is no radiologically confirmed single spontaneous or traumatic intracranial hemorrhage and is typically associated with chronic bleeding sources, such as cranial or spinal dural defects. In contrast, secondary iSS is characterized by the presence of a radiologically identifiable single intracranial hemorrhagic event, either spontaneous or traumatic, which is considered the likely cause of the siderosis. Patients typically present with SS in the fourth to sixth decades of life. The prevalence of SS has been increasing in recent years due to the more widespread use of magnetic resonance imaging (MRI). Early imaging and diagnosis are crucial for identifying the bleeding source and enabling timely intervention, which may prevent further neurological deterioration. We report the case of a 69-year-old woman with a history of subdural hematoma and surgical intervention who presented with progressive bilateral hearing loss, imbalance, headache, and hypogeusia. MRI of the brain revealed classical imaging features of SS. Although further evaluation was recommended, the patient declined extensive diagnostic work-up. Empirical treatment with the iron-chelating agent deferiprone was initiated. This case highlights the diagnostic challenges of SS and emphasizes the importance of comprehensive imaging and early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.